CompanyDrug

Japan’s MHLW Reviews GSK’s Nucala for Chronic Rhinosinusitis with Nasal Polyps Indication

CompanyDrug

Eli Lilly’s Verzenios Receives NMPA Approval for Extended Indication in Early-Stage Breast Cancer

CompanyDeals

Shanghai Biotech Cataya Secures $35 Million in Series B Financing for Synthetic Biology

CompanyDrug

Shanghai Junshi Biosciences’ JS207 Bispecific Antibody Receives NMPA Clinical Trial Approval

CompanyDeals

XtalPi Partners with Parthenon Therapeutics to Harness AI for Solid Tumor Antibody Development

CompanyDrug

United Laboratories’ UBT251 Receives Tacit Approval for Obesity Clinical Study in China

CompanyDrug

Zai Lab’s Margenza (Margetuximab) Approved by China’s NMPA for HER2-Positive Breast Cancer

CompanyDrug

MicuRx Pharmaceuticals Initiates Phase III Trial for MRX-4 in Complex Skin Infections

CompanyDeals

EOC Pharma Group and Nanopeptide Biotechnology Forge Partnership for siRNA Drug Development

CompanyMedical Device

Rapid Medical’s Tigertriever Receives Chinese Approval as Adjustable Thrombectomy Device

CompanyDrug

Genexine’s Eftansomatropin Alfa Achieves Phase III Endpoints in Growth Hormone Deficiency Trial

CompanyDeals

Huadong Medicine Secures Exclusive Rights to MC2 Therapeutics’ Plaque Psoriasis Therapy in China